Vimta Labs Q2 FY27 Income Up 9.9% YoY to ₹1,149 Mn

Vimta Labs Limited announced its unaudited financial results for the second quarter and half year ended September 30, 2026. For Q2 FY27, the company reported a Total Income of ₹1,149 Million, a 9.9% increase year-on-year. EBITDA stood at ₹408 Million with a margin of 35.5%, and Profit After Tax (PAT) was ₹206 Million, a 3.5% rise YoY, with a PAT margin of 17.9%. For the half year ended H1 FY27, Total Income grew 11.8% YoY to ₹2,278 Million, and EBITDA increased by 13.2% to ₹819 Million. The company highlighted steady, profitable growth, driven by pharmaceutical and food research and testing services, and noted the commencement of revenue from its biologics CRAD services as a significant milestone. Management expressed confidence in sustained growth and long-term value creation.